Loading...
XNYS
CAH
Market cap38bUSD
Jun 12, Last price  
160.52USD
1D
4.55%
1Q
25.41%
Jan 2017
123.04%
Name

Cardinal Health Inc

Chart & Performance

D1W1MN
No data to show
P/E
44.97
P/S
0.17
EPS
3.57
Div Yield, %
1.26%
Shrs. gr., 5y
-3.88%
Rev. gr., 5y
9.28%
Revenues
226.83b
+10.64%
74,910,700,00081,363,600,00086,852,000,00091,091,400,00099,512,400,00098,502,800,000102,644,200,000107,552,000,000101,093,000,00091,084,000,000102,531,000,000121,546,000,000129,976,000,000136,809,000,000145,534,000,000152,922,000,000162,467,000,000181,364,000,000205,012,000,000226,827,000,000
Net income
852m
+226.44%
1,050,700,0001,000,100,0001,931,100,0001,300,600,0001,151,600,000642,200,000959,000,0001,069,000,000334,000,0001,166,000,0001,215,000,0001,427,000,0001,288,000,000256,000,0001,363,000,000-3,693,000,000611,000,000-932,000,000261,000,000852,000,000
CFO
3.76b
+32.51%
2,850,200,0002,140,300,0001,223,100,0001,512,100,0001,567,300,0002,134,100,0001,394,600,0001,176,000,0001,727,000,0002,524,000,0002,540,000,0002,971,000,0001,184,000,0002,768,000,0002,722,000,0001,960,000,0002,429,000,0003,122,000,0002,839,000,0003,762,000,000
Dividend
Oct 01, 20240.5056 USD/sh
Earnings
Aug 12, 2025

Profile

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
URL
https://www.cardinalhealth.com/en.html
IPO date
Aug 04, 1983
Employees
47,040
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
226,827,000
10.64%
205,012,000
13.04%
181,364,000
11.63%
Cost of revenue
224,413,000
202,957,000
174,819,000
Unusual Expense (Income)
NOPBT
2,414,000
2,055,000
6,545,000
NOPBT Margin
1.06%
1.00%
3.61%
Operating Taxes
348,000
376,000
163,000
Tax Rate
14.42%
18.30%
2.49%
NOPAT
2,066,000
1,679,000
6,382,000
Net income
852,000
226.44%
261,000
-128.00%
(932,000)
-252.54%
Dividends
(499,000)
(525,000)
(559,000)
Dividend yield
2.05%
2.12%
3.83%
Proceeds from repurchase of equity
(750,000)
(2,000,000)
(1,000,000)
BB yield
3.09%
8.07%
6.86%
Debt
Debt current
434,000
792,000
580,000
Long-term debt
5,133,000
7,818,000
9,470,000
Deferred revenue
(8,654,000)
(9,302,000)
Other long-term liabilities
8,035,000
4,000
9,302,000
Net debt
391,000
13,220,000
5,256,000
Cash flow
Cash from operating activities
3,762,000
2,839,000
3,122,000
CAPEX
(511,000)
(481,000)
(387,000)
Cash from investing activities
(1,849,000)
(454,000)
567,000
Cash from financing activities
(847,000)
(3,051,000)
(2,463,000)
FCF
(636,000)
4,060,000
7,269,000
Balance
Cash
5,133,000
4,043,000
4,717,000
Long term investments
43,000
(8,653,000)
77,000
Excess cash
Stockholders' equity
2,465,000
2,063,000
2,422,000
Invested Capital
9,915,000
(1,243,000)
4,609,000
ROIC
47.65%
99.76%
100.99%
ROCE
24.35%
27.73%
47.06%
EV
Common stock shares outstanding
247,000
262,000
279,000
Price
98.32
3.97%
94.57
80.93%
52.27
-8.44%
Market cap
24,285,040
-1.99%
24,777,340
69.90%
14,583,330
-13.11%
EV
24,677,040
37,998,340
19,842,330
EBITDA
3,124,000
2,747,000
7,237,000
EV/EBITDA
7.90
13.83
2.74
Interest
67,000
93,000
149,000
Interest/NOPBT
2.78%
4.53%
2.28%